Suppr超能文献

用于管理急性术后疼痛的盐酸芬太尼患者自控离子导入透皮系统。

Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.

作者信息

Mayes Stacey, Ferrone Marcus

机构信息

Baptist Medical Center Downtown and Wolfson Children's Hospital, Jacksonville, FL 32207, USA.

出版信息

Ann Pharmacother. 2006 Dec;40(12):2178-86. doi: 10.1345/aph.1H135.

Abstract

OBJECTIVE

To summarize the pharmaceutics, pharmacokinetics, development, and clinical application of IONSYS, the fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.

DATA SOURCES

Clinical literature including both primary sources and review articles was accessed through a search of the MEDLINE databases (1980-October 2006). Key search terms included cutaneous analgesia, fentanyl, IONSYS, opioid, postoperative pain, and patient-controlled analgesia (PCA). Additional clinical trial and drug data were supplied by the manufacturer, the ALZA Corporation.

STUDY SELECTION AND DATA EXTRACTION

Review articles, abstracts, and clinical studies related to patient-controlled iontophoretic transdermal fentanyl and postoperative pain management were analyzed. An evaluation of the research exploring IONSYS for the management of acute postoperative pain was conducted. Relevant information was then selected and is provided in this article.

DATA SYNTHESIS

IONSYS is the first iontophoretic transdermal drug delivery system that utilizes low-level electrical energy to actively transport ionized fentanyl HCl through intact skin. Research has revealed that use of IONSYS for patients with acute postoperative pain is safe, effective, and well tolerated. Phase I-III trials have demonstrated an appropriate dosing range leading to effective analgesia, with minimal adverse effects. The analgesia provided by this system was found to be superior to that of analgesia placebo and equivalent to that of an intravenous morphine PCA.

CONCLUSIONS

Data from clinical trials indicated that IONSYS is successful in controlling acute postoperative pain that circumvents the limitations of intravenous patient-controlled analgesia. The use of this system may serve as an alternative modality for the management of acute pain without increasing such adverse effects as bleeding, intravenous catheter infiltration, or manual pump malfunction.

摘要

目的

总结IONYSYS(用于术后急性疼痛管理的盐酸芬太尼患者自控离子电渗透皮给药系统)的药剂学、药代动力学、研发情况及临床应用。

资料来源

通过检索MEDLINE数据库(1980年至2006年10月)获取包括原始资料和综述文章在内的临床文献。关键检索词包括皮肤镇痛、芬太尼、IONYSYS、阿片类药物、术后疼痛和患者自控镇痛(PCA)。其他临床试验和药物数据由制造商阿尔扎公司提供。

研究选择与数据提取

分析与患者自控离子电渗透皮芬太尼及术后疼痛管理相关的综述文章、摘要和临床研究。对探索IONYSYS用于术后急性疼痛管理的研究进行评估。然后选择相关信息并在本文中提供。

数据综合

IONYSYS是首个利用低水平电能将离子化盐酸芬太尼主动透过完整皮肤进行输送的离子电渗透皮给药系统。研究表明,IONYSYS用于术后急性疼痛患者安全、有效且耐受性良好。I - III期试验已证明其有合适的给药范围,可产生有效的镇痛效果,且不良反应最小。该系统提供的镇痛效果优于镇痛安慰剂,与静脉注射吗啡PCA相当。

结论

临床试验数据表明,IONYSYS成功控制了术后急性疼痛,克服了静脉注射患者自控镇痛的局限性。使用该系统可作为急性疼痛管理的替代方式,而不会增加出血、静脉导管渗漏或手动泵故障等不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验